11 Greenway Plaza,Suite 1000
Houston , TX, 77046-1173
Houston , TX, 77046-1173
Summary
The fund seeks capital appreciation in the long term by investing in companies across any size outside the United States.
The investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.
Next, the research team invests in securities of issuers engaged primarily in health care-related industries, More
Link
Directors
Jan 16, 2024- Beth Ann Brown
- Cynthia Hostetler
- Eli Jones
- Robert C. Troccoli
- Teresa M. Ressel
- Elizabeth Krentzman
- Daniel S. Vandivort
- Anthony J. LaCava, Jr.
- Martin L. Flanagan
- Joel W. Motley
- Prema Mathai-Davis
Chief Compliance Officer
- Todd F. Kuehl
Fund Manager(s)
Price
- 52-Week High/Low
- $42.72 - $35.26
- Turnover
- 44%
- Expense Ratio
- 1.06%
Company Name |
Holding |
Eli Lilly and Co. | 8.5 % |
Boston Scientific Corp. | 5.8 % |
UnitedHealth Group Inc. | 5.23 % |
McKesson Corp. | 4.28 % |
Danaher Corp. | 4.24 % |
Vertex Pharmaceuticals Inc. | 3.89 % |
Intuitive Surgical, Inc. | 3.82 % |
Merck & Co., Inc. | 3.72 % |
AstraZeneca PLC | 3.63 % |
Regeneron Pharmaceuticals, Inc. | 3.56 % |
More | 3.56 % |
Documents
Performance
YTD
-
3 Year
-10.1%
5 Year
-14.21%
Best
57.89%
1991
Worst
-28.36%
2008
2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
---|---|---|---|---|---|---|---|---|---|---|
Q1 | - | 10.4% | -2.6% | -8.3% | -22.5% | -16.5% | 11.8% | -2.6% | 8.9% | -13% |
Q2 | - | -2.1% | 5.5% | -10.9% | 35.5% | 16.6% | 3% | 8.1% | 4.8% | 3.6% |
Q3 | - | - | -6.1% | -4.6% | -19.7% | -1% | -4.6% | 11.8% | 4.7% | 4% |
Q4 | - | - | 7.1% | 10.8% | 6% | 11.4% | 15.4% | -12.9% | -4.1% | -5.9% |
J | F | M | A | M | J | J | A | S | O | N | D | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025 | - | - | - | - | - | - | - | - | - | - | - | - |
2024 | 3.2% | 4.3% | 2.5% | -2.8% | - | - | - | - | - | - | - | - |
2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
0% | 7% | 3% | -14% | -11% | 7% | 27% | 0% | 16% | 0% |
Alpha
2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
---|---|---|---|---|---|---|---|---|---|---|
GGHCX | - | 7% | 3% | -14% | -11% | 7% | 27% | 0% | 16% | - |
S&P 500 | - | - | - | -21% | 27% | 16% | 29% | -6% | 19% | 10% |
Alpha | - | 7% | 3% | 8% | -38% | -9% | -1% | 7% | -4% | - |